皮带治疗对腰部疼痛的短期影响:从单中心回顾性研究的第一个见解
Nur Gökçe Aydın1, Osman Faruk Bayramlar2
1Department of Medical Ecology and Hydroclimatology, Samsun Training and Research Hospital, Samsun Eğitim ve Araştırma Hastanesi Kışla, Barış Blv. No:199, İlkadım/Samsun, Turkey. ngokceaydin@gmail.com.
International journal of biometeorology
|June 11, 2025
概括
皮洛伊德疗法是一种疗法,在慢性腰痛 (CLBP) 患者中显著改善了疼痛和功能. 这种非药物治疗为CLBP管理提供了具有成本效益的替代方案.
科学领域:
- 类风湿病学 类风湿病学
- 物理医学和康复 康复
- 治疗方式 治疗方式
背景情况:
- 慢性腰部疼痛 (CLBP) 是一种广泛的疾病,影响生活质量和医疗费用.
- 寻求有效的非药物治疗方法来管理CLBP并减少对药物治疗的依赖.
研究的目的:
- 评估皮洛伊德疗法在治疗CLBP的短期临床疗效.
- 评估皮质治疗对疼痛,残疾和患者整体幸福感的影响.
主要方法:
- 对263名CLBP患者进行了回顾性分析,这些患者接受了皮洛伊德治疗 (7-15天).
- 结果措施包括健康评估问卷 (HAQ),奥斯威斯特残疾指数 (ODI) 和疼痛和全球评估的视觉模拟尺度 (VAS).
- 统计分析包括配对的t测试,ANOVA和多重线性回归.
主要成果:
- 在治疗后的所有结果测量中观察到显著的改善 (p < 0.001).
- 在HAQ,ODI和VAS得分的实质性降低具有很大的效果大小 (科恩d>1.0).
- 较长的治疗时间和非工作状态与更大的功能改善相关.
结论:
- 皮洛伊德治疗在减少CLBP患者的疼痛和改善功能方面显示出显著的短期疗效.
- 它提供了一个具有成本效益和可访问的非药物治疗选择.
- 这些发现支持将皮质治疗纳入全面的CLBP管理策略.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
140
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
140
01:17Drugs for Treatment of Diarrhea-Predominant IBS
151
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
151